1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow SLE: new trials by email Literature Review of SLE trials Research Report on SLE
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE) Mycophenolate Mofetil, Hydroxychloroquine or Chloroquine, Prednisone - Systemic Lupus Erythematosus, SLE | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 102 | 2013-11-20 | 2020-08-17 |
Lupus Erythematosus, Systemic (1)
Autoimmune Diseases (1) · Connective Tissue Diseases (1) · Immune System Diseases (1) · Skin and Connective Tissue Diseases (1)
Adrenal Cortex Hormones (1) · Chloroquine (1) · Hydroxychloroquine (1) · Mycophenolic Acid (1) · Prednisone (1) · chloroquine diphosphate (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (1)
Eliza Chakravarty, MD (1) · Judith A. James, MD, PhD (1)